Longboard Pharmaceuticals, Inc.
LBPHDelisted Dec 2, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001832168
Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Longboard Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 105 | 1 | 100 | −4 |
| Shares | 37.9M | 25.0K | 38.8M | +884.6K (+2.3%) |
| Value | $819.5M | $540.7K | $1.05B | +$229.5M (+28.0%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Emerald Advisers, LLC | 228,523 | $6.18M | 0.26% |
| Candriam Luxembourg S.C.A. | 225,917 | $6.11M | 0.04% |
| Braidwell LP | 205,926 | $5.57M | 0.17% |
| Emerald Mutual Fund Advisers Trust | 183,577 | $4.96M | 0.26% |
| Lynx1 Capital Management LP | 167,317 | $4.52M | 1.63% |
| Silverarc Capital Management, LLC | 122,849 | $3.32M | 0.82% |
| Saturn V Capital Management LLC | 71,442 | $1.93M | 0.73% |
| UBS Asset Management Americas Inc | 50,056 | $1.35M | 0.00% |
| Alps Advisors Inc | 26,239 | $709.2K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 21,242 | $574.2K | 0.03% |
| Corebridge Financial, Inc. | 17,400 | $470.3K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 13,016 | $351.8K | 0.00% |
| Janus Henderson Group PLC | 12,300 | $332.3K | 0.00% |
| State Board of Administration of Florida Retirement System | 9,015 | $243.7K | 0.00% |
| Arizona State Retirement System | 7,994 | $216.1K | 0.00% |
| Allianz Asset Management GmbH | 7,700 | $208.1K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 4,716 | $127.5K | 0.00% |
| Virtus ETF Advisers LLC | 4,538 | $122.7K | 0.06% |
| Danske Bank A/S | 700 | $18.9K | 0.00% |
| CWM, LLC | 1 | $0 | 0.00% |
Sold out (24)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (1)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 25,034 | $540.7K |